It was recently reported that effectors derived from naïve T cells are superior in tumor control compared to the effectors that were derived from central memory CD8 T cells, with apparently enhanced proliferative potential, enhanced cytokine production, as well as the lack of KLRG-1, a marker for proliferative senescence [46]. The gene discussed is KLRG1; the disease is neoplasm.